BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16495030)

  • 1. A simple and rapid assay for heparanase activity using homogeneous time-resolved fluorescence.
    Enomoto K; Okamoto H; Numata Y; Takemoto H
    J Pharm Biomed Anal; 2006 Jun; 41(3):912-7. PubMed ID: 16495030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity.
    Nardella C; Steinkühler C
    Anal Biochem; 2004 Sep; 332(2):368-75. PubMed ID: 15325306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of high-throughput spermidine synthase activity assay using homogeneous time-resolved fluorescence.
    Enomoto K; Nagasaki T; Yamauchi A; Onoda J; Sakai K; Yoshida T; Maekawa K; Kinoshita Y; Nishino I; Kikuoka S; Fukunaga T; Kawamoto K; Numata Y; Takemoto H; Nagata K
    Anal Biochem; 2006 Apr; 351(2):229-40. PubMed ID: 16472757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Europium cryptate-tethered ribonucleotide for the labeling of RNA and its detection by time-resolved amplification of cryptate emission.
    Alpha-Bazin B; Bazin H; Boissy L; Mathis G
    Anal Biochem; 2000 Nov; 286(1):17-25. PubMed ID: 11038268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents.
    Huang KS; Holmgren J; Reik L; Lucas-McGady D; Roberts J; Liu CM; Levin W
    Anal Biochem; 2004 Oct; 333(2):389-98. PubMed ID: 15450817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies.
    Komatsu N; Waki M; Sue M; Tokuda C; Kasaoka T; Nakajima M; Higashi N; Irimura T
    J Immunol Methods; 2008 Feb; 331(1-2):82-93. PubMed ID: 18162185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrafiltration-based assay for heparanase activity.
    Tsuchida S; Podyma-Inoue KA; Yanagishita M
    Anal Biochem; 2004 Aug; 331(1):147-52. PubMed ID: 15246007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanases and tumor metastasis.
    Nakajima M; Irimura T; Nicolson GL
    J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells.
    Lundin K; Blomberg K; Nordström T; Lindqvist C
    Anal Biochem; 2001 Dec; 299(1):92-7. PubMed ID: 11726189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.
    Marchetti D; Li J; Shen R
    Cancer Res; 2000 Sep; 60(17):4767-70. PubMed ID: 10987284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
    Ricoveri W; Cappelletti R
    Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prostate carcinoma cells produce extracellular heparanase.
    Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
    J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new methods for determining the heparanase enzymatic activity.
    Melo CM; Tersariol IL; Nader HB; Pinhal MA; Lima MA
    Carbohydr Res; 2015 Aug; 412():66-70. PubMed ID: 26062789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A separation-free assay for the detection of mutations: combination of homogeneous time-resolved fluorescence and minisequencing.
    Lopez-Crapez E; Bazin H; Chevalier J; Trinquet E; Grenier J; Mathis G
    Hum Mutat; 2005 May; 25(5):468-75. PubMed ID: 15832307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of simple heparanase substrates.
    Pearson AG; Kiefel MJ; Ferro V; von Itzstein M
    Org Biomol Chem; 2011 Jun; 9(12):4614-25. PubMed ID: 21505696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate.
    Schiemann S; Lühn S; Alban S
    Anal Biochem; 2012 Aug; 427(1):82-90. PubMed ID: 22579846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence.
    Park YW; Cummings RT; Wu L; Zheng S; Cameron PM; Woods A; Zaller DM; Marcy AI; Hermes JD
    Anal Biochem; 1999 Apr; 269(1):94-104. PubMed ID: 10094779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.